Lucier Named to NuVasive Board of Directors

New member is CEO of Life Technologies Corporation.

Author Image

By: Michael Barbella

Managing Editor

NuVasive Inc. has named Gregory T. Lucier to its Board of Directors. Lucier is chairman and CEO of Life Technologies Corporation, a global life sciences company that recently was acquired by Thermo Fisher Scientific.

“We are exceptionally pleased to appoint Mr. Lucier to the NuVasive Board of Directors, and look forward to his contributions,” NuVasive Chairman/CEO Alex Lukianov said. “His wealth of experience building and leading a growth company with a performance innovation culture will further strengthen the depth of our board and complement the existing team well. Our ability to draw upon his prominent leadership in Life Technologies’ international expansion will also be invaluable as we continue the execution of a global market share taking strategy and drive toward our next milestone of becoming a $1 Billion startup.”

Throughout his 10 years as Chairman and CEO of Life Technologies, Lucier helped transform the company from a narrow $600 million biotechnology tools firm into one of the world’s largest life sciences companies with sales approaching $4 billion. As Life Technologies expanded rapidly outside of the United States, Lucier championed this development by forming key local relationships, hiring leadership, and investing in infrastructure to extend the company’s reach, driving international sales to more than 51 percent of total revenue.

Prior to Life Technologies, Lucier held several senior management positions with General Electric Company from 1995 to 2003, most recently as CEO/president of Medical Systems Information Technologies for GE Healthcare.

Lucier earned a Bachelor of Science degree in industrial engineering from Pennsylvania State University and a Master’s in business administration from Harvard Graduate School of Business Administration. Lucier serves on numerous boards.

Based inSan Diego,Calif., NuVasive develops minimally invasive spinal surgery products. The company claims it is the fourth largest player in the $8.2 billion global spinal market.

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters